|
||||||||||||||||||||||
![]() |
|
![]() |
![]() |
|
![]() monoclonal antibody CC49-delta CH2 A humanized CH2 domain-deleted second-generation monoclonal antibody based on the antibody B72.3 that is directed against tumor-associated glycoprotein 72 (TAG72). TAG72 is expressed by gastric, breast, pancreatic, colorectal, and ovarian carcinoma cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus) ![]()
![]() ![]() ![]() |
![]() |
![]() |
![]() |
![]() |
NCI Home |
Images Version |
Contact Us |
Policies |
Accessibility |
Viewing Files |
FOIA |
Site Help |
Site Map
|
![]() A Service of the National Cancer Institute |
![]() |
![]() |